- Hypopigmentation Induced by Frequent Low-Fluence, Large-Spot-Size QS Nd:YAG Laser Treatments
-
Wong Y, Lee SS, Goh CL
- KMID: 2157454
- Ann Dermatol.
- 2015 Dec;27(6):751-755.
- doi: 10.5021/ad.2015.27.6.751
The Q-switched 1064-nm neodymium-doped yttrium aluminum garnet (QS 1064-nm Nd:YAG) laser is increasingly used for nonablative skin rejuvenation or "laser toning" for melasma. Multiple and frequent low-fluence, large-spot-size treatments are... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis of Seronegative Rheumatoid Arthritis by 68 Ga‑FAPI PET/CT
-
Cheung S, Chen S, Wong Y, Wu K, Ho C
- KMID: 2539529
- Nucl Med Mol Imaging.
- 2023 Feb;57(1):44-45.
- doi: 10.1007/s13139-022-00779-x
Early diagnosis of rheumatoid arthritis with the initiation of disease-modifying antirheumatic drugs is important to prevent future disability. Seronegative rheumatoid arthritis lacks the classical immunological markers, thus imposing clinical diagnostic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Prospective 1-Year Follow-Up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection
-
Lui DTW, Lee CH, Wong Y, Fong CHY, Tsoi KH, Woo YC, Tan KCB
- KMID: 2558043
- Diabetes Metab J.
- 2024 Jul;48(4):763-770.
- doi: 10.4093/dmj.2023.0175
Background: We evaluated changes in glycemic status, over 1 year, of coronavirus disease 2019 (COVID-19) survivors with dysglycemia in acute COVID-19. Methods: COVID-19 survivors who had dysglycemia (defined by glycosylated hemoglobin... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus
-
Lee CH, Wu MZ, Lui DTW, Chan DSH, Fong CHY, Shiu SWM, Wong Y, Lee ACH, Lam JKY, Woo YC, Lam KSL, Yiu KKH, Tan KCB
- KMID: 2536143
- Diabetes Metab J.
- 2022 Nov;46(6):843-854.
- doi: 10.4093/dmj.2021.0319
Background: Insulin-treated patients with long duration of type 2 diabetes mellitus (T2DM) are at increased risk of ketoacidosis related to sodium-glucose co-transporter 2 inhibitor (SGLT2i). The extent of circulating ketone... -
- CITED
-
- Close
- SHARE
-
- Close
